Works matching AU Kim, Bo Kyung


Results: 155
    1
    2
    3
    4
    5
    6

    Anti-proteolytic regulation of KRAS by USP9X/NDRG3 in KRAS-driven cancer development.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-024-54476-8
    By:
    • Koo, Han;
    • Park, Kyung Chan;
    • Sohn, Hyun Ahm;
    • Kang, Minho;
    • Kim, Dong Joon;
    • Park, Zee-Yong;
    • Park, Sehoon;
    • Min, Sang Hyun;
    • Park, Seong-Hwan;
    • You, Yeon-Mi;
    • Han, Yohan;
    • Kim, Bo-Kyung;
    • Lee, Chul-Ho;
    • Kim, Yeon-Soo;
    • Chung, Sang J.;
    • Yeom, Young Il;
    • Lee, Dong Chul
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Synaptotagmin 11 scaffolds MKK7–JNK signaling process to promote stem-like molecular subtype gastric cancer oncogenesis.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02420-3
    By:
    • Kim, Bo-Kyung;
    • Kim, Da-Mi;
    • Park, Hyunkyung;
    • Kim, Seon-Kyu;
    • Hwang, Mi-Aie;
    • Lee, Jungwoon;
    • Kang, Mi-Jung;
    • Byun, Jae-Eun;
    • Im, Joo-Young;
    • Kang, Minho;
    • Park, Kyung Chan;
    • Yeom, Young Il;
    • Kim, Seon-Young;
    • Jung, Haiyoung;
    • Kweon, Dae-Hyuk;
    • Cheong, Jae-Ho;
    • Won, Misun
    Publication type:
    Article
    31
    32
    33
    34
    35

    CYB5R3 functions as a tumor suppressor by inducing ER stress-mediated apoptosis in lung cancer cells via the PERK-ATF4 and IRE1α-JNK pathways.

    Published in:
    Experimental & Molecular Medicine EMM, 2024, v. 56, n. 1, p. 235, doi. 10.1038/s12276-024-01155-9
    By:
    • Im, Joo-Young;
    • Kim, Soo Jin;
    • Park, Jong-Lyul;
    • Han, Tae-Hee;
    • Kim, Woo-il;
    • Kim, Inhyub;
    • Ko, Bomin;
    • Chun, So-Young;
    • Kang, Mi-Jung;
    • Kim, Bo-Kyung;
    • Jeon, Sol A.;
    • Kim, Seon-Kyu;
    • Ryu, Incheol;
    • Kim, Seon-Young;
    • Nam, Ki-Hoan;
    • Hwang, Inah;
    • Ban, Hyun Seung;
    • Won, Misun
    Publication type:
    Article
    36
    37

    DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor–resistant lung cancer therapy.

    Published in:
    Experimental & Molecular Medicine EMM, 2022, v. 54, n. 8, p. 1236, doi. 10.1038/s12276-022-00836-7
    By:
    • Heo, Haejeong;
    • Kim, Jong-Hwan;
    • Lim, Hyun Jung;
    • Kim, Jeong-Hwan;
    • Kim, Miso;
    • Koh, Jaemoon;
    • Im, Joo-Young;
    • Kim, Bo-Kyung;
    • Won, Misun;
    • Park, Ji-Hwan;
    • Shin, Yang-Ji;
    • Yun, Mi Ran;
    • Cho, Byoung Chul;
    • Kim, Yong Sung;
    • Kim, Seon-Young;
    • Kim, Mirang
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50